Gene-Targeted Drug Tagrisso Cuts Death Rate in Half for Patients With Early-Stage Lung Cancer
TUESDAY, June 6, 2023 (HealthDay News) — Once-a-day use of the targeted cancer pill Tagrisso (osimertinib) cut the five-year death rate in half for a subset of patients with early-stage lung cancer, a new clinical trial shows.The results could have m…
Learn MoreASCO: Lack of Benefit Seen for Indefinite-Duration Immunotherapy in NSCLC
TUESDAY, June 6, 2023 (HealthDay News) — For patients with advanced non-small cell lung cancer (NSCLC), indefinite duration of immunotherapy treatment does not seem to offer benefits over fixed-duration therapy for two years, according to a study pub…
Learn MoreMen: Here Are the Health Screenings You Need
MONDAY, June 5, 2023 (HealthDay News) — Many men will put off going to the doctor unless they are really sick, but men’s health screenings help catch problems before symptoms appear.So, how can you tell if a health screening or preventive care appoin…
Learn MoreCanada to Become 1st Country to Mandate Warning Labels on Individual Cigarettes
THURSDAY, June 1, 2023 (HealthDay News) – Smokers in Canada will soon see health warnings on each and every cigarette they light up..The country will be the first in the world to print these warnings directly on individual cigarettes.“This bold step w…
Learn MoreSurgical Treatment Provides Better Long-Term Survival for NSCLC
MONDAY, May 22, 2023 (HealthDay News) — Long-term survival favors surgical management over stereotactic body radiotherapy (SBRT) for treatment of early-stage, non-small cell lung cancer (NSCLC), according to a study presented at the annual meeting of…
Learn MoreEl aire contaminado y el cáncer de pulmón: un estudio de Detroit muestra la importancia del vecindario
MARTES, 9 de mayo de 2023 (HealthDay News) — ¿El lugar en que vive afecta a su riesgo de cáncer de pulmón? Es posible, advierten los expertos.Aunque fumar cigarrillos es la causa principal de la mayoría de los cánceres de pulmón, una nueva investigac…
Learn MoreCemiplimab + Chemotherapy Aids Quality of Life With Lung Cancer
WEDNESDAY, May 10, 2023 (HealthDay News) — Cemiplimab plus chemotherapy results in significant overall improvement in pain symptoms and delayed deterioration in cancer-related and lung cancer-specific symptoms and functions, according to a study publ…
Learn MoreSurgery Beats Targeted Radiation for Patients Battling Early Stage Lung Cancer
WEDNESDAY, May 10, 2023 (HealthDay News) — More patients are choosing radiation therapy over surgery to treat their early-stage lung cancer, but a new study argues they might be making a mistake.People who are good surgical candidates for lung cancer…
Learn MoreDejar de fumar antes siempre es mejor para la supervivencia al cáncer de pulmón
LUNES, 8 de mayo de 2023 (HealthDay News) — Dejar de fumar ofrecerá un beneficio, incluso a las personas que luego reciben un diagnóstico de cáncer de pulmón, indica una investigación reciente.Aunque con frecuencia los estudios comparan los resultado…
Learn MoreDirty Air & Lung Cancer: Detroit Study Shows How Your Neighborhood Matters
TUESDAY, May 9, 2023 (HealthDay News) — Does where you live affect your risk for lung cancer? Just possibly, experts warn.Although cigarette smoking is the principal cause of most lung cancers, new research has found evidence that Americans who live …
Learn More